Product
BPX-501 and Rimiducid
1 clinical trial
5 indications
Indication
Primary Immune Deficiency DisordersIndication
Hemophagocytic LymphohistiocytosisIndication
Inherited Bone Marrow Failure SyndromeIndication
HemoglobinopathiesIndication
Metabolic DisordersClinical trial
A Study Evaluating BPX-501 T Cells and AP1903 for Prevention of Graft Versus Host Disease (GVHD) After Haploidentical, Related, T Cell-Depleted Hematopoietic Cell Transplantation for Non-Malignant DiseasesStatus: Terminated, Estimated PCD: 2015-09-01